Latest financial market updates and expert analysis
Analysis Bayer enters a defining week as two parallel tracks converge: a US Supreme Court hearing on Monday that could reshape its glyphosate litigation landscape, and shareholder approval for a €7...
BioNTech enters its most consequential two-week stretch of the year with a packed corporate calendar that will test investor confidence...
Nel ASA’s shares have clawed back more than 23 percent from their March low, closing last week at €0.22 after...
The disconnect between Lynas Rare Earths’ operational achievements and its stock performance has rarely been wider. The Australian miner just...
The French biotech group Valneva finds itself at a critical juncture, with its share price pinned to a 52-week low...
The industrial printer is paying a steep price for its ambition. Heidelberger Druckmaschinen has been forced to walk back its...
The month of May is shaping up as a defining moment for Realty Income, with the net-lease REIT set to...
A quarter that many in the market had braced for disappointment delivered the opposite. SAP’s first-quarter results for 2026 landed...
The math at Take-Two Interactive tells two very different stories right now. For the fiscal fourth quarter ending in March,...
IBM kicked off 2026 with a textbook “beat and raise” quarter, yet the market response was anything but textbook. Shares...
The numbers coming out of Aixtron’s first quarter paint a picture of stark contrasts. While the stock has surged roughly...
